Reduced levels of miR-124-3p have been observed in ovarian cancer patients, suggesting its potential tumor-suppressive function through the modulation of NEAT1 expression (Chai et al., 2016[7]). This evidence concerns the gene NEAT1 and ovarian carcinoma.